Alternatives to NewStem

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

EU-based company providing personalized medicine solutions for medical practitioners.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Specialized services for pharmaceutical and life sciences clients across product development and commercialization.

Unleashing the power of genomics at scale for biological advances and human health.

Building General Biological Intelligence

AI-enabled technology for cell biology research and biopharma development.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Life sciences data platform for deep-phenotype multi-omics datasets.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.

Developing novel therapeutics for rare genetic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Advanced infectious disease diagnostics

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.